JW (Cayman) Therapeutics Co. Ltd
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, inclu…
Biotechnology
CN, Shanghai [HQ]
2126.HK/Financial Reporting
Income Statements
Profit & Loss · 6 Statements · From 2023 to 2018Configuration
In Million CNY. Margins, Growth Rates In %
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Revenue | - - | 5.00 | - - | 30.00 | 145.00 | 173.00 | |
|
EPS
|
-0.72 | -9.74 | -12.61 | -1.76 | -2.06 | -1.87 | |
| Diluted in mil. | -0.72 | -9.74 | -12.61 | -1.76 | -2.06 | -1.87 | |
|
Profit
|
- - | 5.00 | - - | 9.00 | 58.00 | 88.00 | |
| Gross Margin | 100.00 | 100.00 | - - | 29.37 | 40.33 | 50.74 | |
| Pre Tax | -272.00 | -633.00 | -1,663.00 | -702.00 | -846.00 | -767.00 | |
| Profit Margin | -126,798.14 | -11,549.46 | - - | -2,280.51 | -580.73 | -441.74 | |
| ETR | -41.28 | - - | - - | -4.67 | -7.97 | 0.43 | |
| Net | -272.00 | -633.00 | -1,663.00 | -702.00 | -846.00 | -767.00 | |
| Profit Margin | -126,798.14 | -11,549.46 | - - | -2,280.51 | -580.73 | -441.74 | |
| EBITDA | -152.00 | -194.00 | -454.00 | -738.00 | -629.00 | -473.00 | |
| EBITDA Margin | -70,725.12 | -3,545.56 | - - | -2,398.62 | -432.06 | -272.42 | |
| Operating Income | -112.00 | -203.00 | -467.00 | -771.00 | -697.00 | -789.00 | |
| Operating Margin | -52,200.93 | -3,711.76 | - - | -2,505.82 | -478.49 | -454.17 | |
| Interest Income | 1.00 | - - | 2.00 | 5.00 | 9.00 | 34.00 | |
| Loss | -117.00 | -639.00 | -1,666.00 | -738.00 | -1,001.00 | -744.00 | |
| Cost of Revenue | - - | - - | - - | -21.00 | -86.00 | -85.00 | |
|
Operating Expenses
|
-117.00 | -639.00 | -1,666.00 | -716.00 | -914.00 | -658.00 | |
| R&D | -75.00 | -136.00 | -225.00 | -414.00 | -407.00 | -413.00 | |
| G&A | -20.00 | -72.00 | -231.00 | -201.00 | -179.00 | -64.00 | |
| SG&A | -20.00 | -72.00 | -244.00 | -372.00 | -370.00 | -117.00 | |
| S&M | - - | - - | -13.00 | -170.00 | -190.00 | -53.00 | |
| Depreciation and Amortization | -5.00 | -17.00 | -23.00 | -46.00 | -81.00 | -99.00 | |
| Interest Expenses | -2.00 | - - | - - | -2.00 | -6.00 | -12.00 | |
| Other Expenses | -160.00 | -429.00 | -1,195.00 | -69.00 | -148.00 | -197.00 | |
|
WA Shares Outstanding
|
376.00 | 65.00 | 131.00 | 399.00 | 410.00 | 411.00 | |
| Diluted | 376.00 | 65.00 | 131.00 | 399.00 | 410.00 | 411.00 |